Treatment interruption after pregnancy: effects on disease progression and laboratory findings
about
Maternal CD4+ cell count decline after interruption of antiretroviral prophylaxis for the prevention of mother-to-child transmission of HIVPregnancy and virologic response to antiretroviral therapy in South AfricaAsking the right questions: developing evidence-based strategies for treating HIV in women and childrenPostpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States.Pregnancy outcomes in women with advanced HIV infection in Italy.Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randMaternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil.Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care.A review of reproductive health research, guidelines and related gaps for women living with HIV.Biomarkers from late pregnancy to 6 weeks postpartum in HIV-infected women who continue versus discontinue antiretroviral therapy after delivery.Impact of HIV-1 infection and pregnancy on maternal health: comparison between perinatally and behaviorally infected young women.Antiretroviral therapy and preterm birth in HIV-infected women.British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review).British HIV Association guidelines for the management of HIV infection in pregnant women 2012
P2860
Q28482652-B82DC1A8-CDAF-4C69-BF74-D8928DC173D9Q28741879-1F4E11E5-EDFC-4E08-BC1F-6ABFC9E98338Q28743488-0E1E7405-DAAC-401C-9995-333B37B49F6CQ33875036-6B85FF94-FD41-4794-8913-9A008C754BABQ35445035-728955CB-A40B-489A-90A3-128B21DADD16Q36086970-FF1E81BA-8234-46D9-A0A2-35BB0AC1658AQ36221392-7D9AFFDC-4204-43C9-A681-BFE6CCAF9D11Q36389902-FDB6D2B9-B0A2-44BA-B14F-24B6370A9519Q36878888-85EB5C08-F093-41E8-A187-381019453A76Q37404428-F357A99B-111A-4710-96ED-5A52F5CCA571Q37551689-AB5B88EA-76C9-4436-A7A6-2230D5AFE223Q38185748-477CD895-2761-4582-8BBC-E29FDA906D02Q38325427-18ECF713-BFDB-4070-A1C8-DE6B05D2291AQ57076282-264308C2-DD45-44FB-8C58-857BE7192EC6
P2860
Treatment interruption after pregnancy: effects on disease progression and laboratory findings
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Treatment interruption after p ...... ession and laboratory findings
@en
Treatment interruption after p ...... ssion and laboratory findings.
@nl
type
label
Treatment interruption after p ...... ession and laboratory findings
@en
Treatment interruption after p ...... ssion and laboratory findings.
@nl
prefLabel
Treatment interruption after p ...... ession and laboratory findings
@en
Treatment interruption after p ...... ssion and laboratory findings.
@nl
P2093
P2860
P356
P1476
Treatment interruption after p ...... ession and laboratory findings
@en
P2093
B Thompson
L M Mofenson
R E Tuomala
P2860
P304
P356
10.1155/2009/456717
P577
2009-11-02T00:00:00Z